Literature DB >> 33550475

Does otosclerosis affect the dimensions of the facial canal and cochlear aquaduct?

Vefa Cakmak1, Pinar Cakmak2.   

Abstract

PURPOSE: Our aim was to evaluate the relationship of the dimensions of the facial canal (FC) and cochlear aqueduct (CA) in otosclerosis (OS) with the type and severity of OS.
METHODS: Two radiologists retrospectively evaluated temporal bone high-resolution computed tomography (HRCT) images obtained from 48 healthy individuals and 94 OS patients between January 2015 and July 2020. In the study group, the CA width, funnel base width, and funnel length, in addition to the FC transverse length, were measured in the axial plane. The CA length was measured in the coronal plane on HRCT images. The FC craniocaudal length was measured in the same plane as the fissula ante fenestram (FAF) in coronal reformatted HRCT images. Grading of OS was based on otosclerotic plaque density and new bone formation extending toward the tympanic cavity at the FAF level.
RESULTS: In the OS patients, the CA width and FC craniocaudal and FC transverse diameters were significantly decreased on both sides compared to those in the control group (p < 0.001). In fenestral OS, the FC craniocaudal and transverse widths on both sides were statistically significantly lower than the FC widths in the control group (p < 0.0001). A statistically negative correlation was found in the FC craniocaudal (r = - 0.831/- 0.818) and transverse (r = - 0.742/- 0.750) measurements on both sides in accordance with an increase in the otosclerotic plaque density (p < 0.0001).
CONCLUSION: The presence of narrowing in the FC and CA adjacent to the FAF supports the role of autoimmunity theory in the etiology of OS.

Entities:  

Keywords:  Cochlear aqueduct; Facial nerve; Multidetector computed tomography; Otosclerosis; Temporal bone

Mesh:

Year:  2021        PMID: 33550475     DOI: 10.1007/s00405-021-06655-2

Source DB:  PubMed          Journal:  Eur Arch Otorhinolaryngol        ISSN: 0937-4477            Impact factor:   2.503


  19 in total

1.  Temporal bone density measurements using CT in otosclerosis.

Authors:  A Bozorg Grayeli; C Saint Yrieix; Y Imauchi; F Cyna-Gorse; E Ferrary; O Sterkers
Journal:  Acta Otolaryngol       Date:  2004-12       Impact factor: 1.494

2.  Diagnostic efficacy and therapeutic impact of computed tomography in the evaluation of clinically suspected otosclerosis.

Authors:  Cristina Dudau; Fakhruddin Salim; Dan Jiang; Steve E J Connor
Journal:  Eur Radiol       Date:  2016-06-30       Impact factor: 5.315

3.  Correlations between CT scan findings and hearing thresholds in otosclerosis.

Authors:  Mathieu Marx; Sebastien Lagleyre; Bernard Escudé; Julie Demeslay; Tarik Elhadi; Olivier Deguine; Bernard Fraysse
Journal:  Acta Otolaryngol       Date:  2011-02-23       Impact factor: 1.494

4.  Are computed tomography and densitometric measurements useful in otosclerosis with mixed hearing loss? A retrospective clinical study.

Authors:  Gokhan Kutlar; Mehmet Koyuncu; Muzaffer Elmali; Figen Basar; Sinan Atmaca
Journal:  Eur Arch Otorhinolaryngol       Date:  2013-10-06       Impact factor: 2.503

Review 5.  An overview of the etiology of otosclerosis.

Authors:  Konstantinos Markou; John Goudakos
Journal:  Eur Arch Otorhinolaryngol       Date:  2008-08-13       Impact factor: 2.503

Review 6.  Otosclerosis: an autoimmune disease?

Authors:  Tamás Karosi; Zoltán Szekanecz; István Sziklai
Journal:  Autoimmun Rev       Date:  2009-03-24       Impact factor: 9.754

Review 7.  Measles.

Authors:  William J Moss
Journal:  Lancet       Date:  2017-06-30       Impact factor: 79.321

8.  Association of COL1A1 and otosclerosis: evidence for a shared genetic etiology with mild osteogenesis imperfecta.

Authors:  M J McKenna; A G Kristiansen; M L Bartley; J J Rogus; J L Haines
Journal:  Am J Otol       Date:  1998-09

9.  Diagnostic Protocol for Detecting Otosclerosis on High-Resolution Temporal Bone CT.

Authors:  Lisa A Brown; Burce Ozgen Mocan; Miriam I Redleaf
Journal:  Ann Otol Rhinol Laryngol       Date:  2019-07-09       Impact factor: 1.547

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.